FABP4 and type 2 diabetes mellitus: We have recently reported that the circulating levels of the fatty acid binding protein 4 (FABP4), reflects the myocardial neutral lipid content in type 2 diabetic patients (Rodriguez-Calvo et al., 2019), thus proposing this molecule as an emerging biomarker for ectopic fat deposition in non-adipose tissues.